Bharat Immunologicals (India) Performance

Bharat Immunologicals Biologicals Corp Ltd -- India Stock  

INR 24.6  0.45  1.8%

On a scale of 0 to 100 Bharat Immunologicals holds performance score of 9. The firm shows Beta (market volatility) of 1.1851 which signifies that as market goes up, the company is expected to significantly outperform it. However, if the market returns are negative, Bharat Immunologicals will likely underperform.. Although it is vital to follow to Bharat Immunologicals historical returns, it is good to be conservative about what you can actually do with the information regarding equity current trending patterns. The philosophy in foreseeing future performance of any stock is to evaluate the business as a whole together with its past performance including all available fundamental and technical indicators. We have found twenty-one technical indicators for Bharat Immunologicals Biologicals Corp Ltd which you can use to evaluate performance of the firm. Please makes use of Bharat Immunologicals Jensen Alpha, Semi Variance and the relationship between Standard Deviation and Value At Risk to make a quick decision on weather Bharat Immunologicals price patterns will revert.
Investment Horizon     30 Days    Login   to change

Bharat Immunologicals Relative Risk vs. Return Landscape

If you would invest  2,155  in Bharat Immunologicals Biologicals Corp Ltd on November 18, 2017 and sell it today you would earn a total of  305  from holding Bharat Immunologicals Biologicals Corp Ltd or generate 14.15% return on investment over 30 days. Bharat Immunologicals Biologicals Corp Ltd is generating 0.736% of daily returns and assumes 4.8868% volatility on return distribution over the 30 days horizon. Simply put, 45% of equities are less volatile than Bharat Immunologicals Biologicals Corp Ltd and 86% of equity instruments are likely to generate higher returns than the company over the next 30 trading days.
 Daily Expected Return (%) 
      Risk (%) 
Assuming 30 trading days horizon, Bharat Immunologicals Biologicals Corp Ltd is expected to generate 10.61 times more return on investment than the market. However, the company is 10.61 times more volatile than its market benchmark. It trades about 0.15 of its potential returns per unit of risk. The DOW is currently generating roughly 0.55 per unit of risk.

9 

Risk-Adjusted Performance

Compared to the overall equity markets, risk-adjusted returns on investments in Bharat Immunologicals Biologicals Corp Ltd are ranked lower than 9 (%) of all global equities and portfolios over the last 30 days.

One Month Efficiency

Bharat Immunologicals Sharpe Ratio = 0.1506
Best
Portfolio
Best
Equity
Good Returns
Average Returns
Small ReturnsBIBCL
CashSmall
Risk
Average
Risk
High
Risk
Huge
Risk
Negative Returns

Estimated Market Risk

 4.89
  actual daily
 
 55 %
of total potential
  

Expected Return

 0.74
  actual daily
 
 14 %
of total potential
  

Risk-Adjusted Return

 0.15
  actual daily
 
 9 %
of total potential
  
Based on monthly moving average Bharat Immunologicals is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Bharat Immunologicals by adding it to a well-diversified portfolio.